We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-21.50 | -1.58% | 1,340.00 | 1,338.50 | 1,339.50 | 1,368.00 | 1,337.50 | 1,363.50 | 3,512,318 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.26 | 56.44B |
Date | Subject | Author | Discuss |
---|---|---|---|
29/4/2009 20:24 | level 5 'pandemic inminent' | ejohn3 | |
29/4/2009 20:23 | OneEyedJack | damian | |
29/4/2009 20:21 | Phase 5 would indicate widespread human-to-human transmission This will go to Phase 6 now no doubt. | oneeyedjack01 | |
29/4/2009 20:16 | put the news on mate | ejohn3 | |
29/4/2009 20:14 | what do u mean level 5? | oneeyedjack01 | |
29/4/2009 20:06 | level 5, sky news now going to confirm drug orders to stock pile straight away. | ejohn3 | |
29/4/2009 19:56 | Lord why should I not keep hold of my shares? Seriously, good reasons. They are at a pretty low point and look just about reading to bounce to me. | oneeyedjack01 | |
29/4/2009 19:49 | OK you've been warned | lord luc4n | |
29/4/2009 19:47 | This is a great buy at this price. Keep it up Wonga... Me and my one eye are with you! | oneeyedjack01 | |
29/4/2009 19:25 | steptoeandson - 29 Apr'09 - 19:58 - 1667 of 1667 Wonga FWEB looks set to double very soon imo and i intend to buy in tomm ----- Sir, £10 real soon, one advised yesterday and one chose to ignore | lord luc4n | |
29/4/2009 19:24 | step - Cant find the FWEB shares you mention, could you tell me where i need to look. Thanks | charles2112 | |
29/4/2009 18:58 | Yeahhh... get your snout in the trough lol. | wongauk | |
29/4/2009 18:55 | I told you £10 So did ANYONE buy this sheet today | lord luc4n | |
29/4/2009 18:54 | steptoe - Blimey. I've done a quick check on this and it looks bloody good. It looks like it's a good target for a take-over bid too according to many. Barclays have it as 'Highly Recommended'. They've also got a 'Buy' recommendation from the same Broker as GSK (Panmure Gordon). Financials look good. I may spreadbet this one at the right time...... will keep an eye on this one. Thanks. | wongauk | |
29/4/2009 18:41 | Interesting! Are GSK about to "take out" Dendreon, and take the entire prostate cancer market all for themselves? :-) | wongauk | |
29/4/2009 18:40 | $30.91 in the US now, thats 1054p uk plus dividend 14p 1068p not to bad. | montyhedge | |
29/4/2009 17:32 | Great post Wonga, well worded: WongaUK - 28 Apr'09 - 21:19 - 1588 of 1656 Dear Lord Lucan, I'm sorry to advise you that nobody takes anything you say seriously or takes any notice of you whatsoever. You have no skills, no knowledge, no talents, and no information or facts to back-up anything you puke up. Nobody is remotely interested in you at all. You're wasting your time here trying to 'get your kicks'..... go get yourself a life somewhere. Maybe you have a friend or Doctor you can confide in? This is intended to be a polite message. Get help man. Regards, Wonga. | bailiffs | |
29/4/2009 16:22 | I think that good news on three fronts (Relenza, Avodart, Alli). We seem to have very strong support at £10, and a dividend yield above 5%. Moreover, a good defensive stock is essential in anyones portfolio at this time. Not spectacular growth, but solid and safe. Nobrainer. I am heavily loaded into this stock in my isa and will top up again if it drops anywhere near £10. Good luck all. | oilgetmecoat |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions